TITLE:
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)

CONDITION:
Major Depressive Disorder

INTERVENTION:
MK0869, aprepitant

SUMMARY:

      A clinical study to determine the efficacy and safety of MK0869 in the treatment of
      depression
    

DETAILED DESCRIPTION:

      The duration of treatment is 8 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Major Depressive Disorder
      
